ProfileGDS5678 / 1421448_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 49% 51% 50% 55% 50% 48% 48% 50% 51% 52% 50% 51% 50% 52% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.2285449
GSM967853U87-EV human glioblastoma xenograft - Control 23.2172951
GSM967854U87-EV human glioblastoma xenograft - Control 33.2115450
GSM967855U87-EV human glioblastoma xenograft - Control 43.3296355
GSM967856U87-EV human glioblastoma xenograft - Control 53.1558850
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.2391848
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.2155348
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.1930350
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.2011251
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.2432952
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.2029750
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.2048451
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.2157950
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.2630252